Recent research into autoimmune diseases like Sjögren's Syndrome has focused on developing targeted therapies. These treatments aim to reduce harmful immune cells by targeting specific proteins involved in the immune response. For instance, researchers have developed an afucosylated anti-CXCR5 antibody designed to block certain interactions and promote the removal of harmful cells through antibody-dependent cellular cytotoxicity (ADCC).
This approach could lead to more precise treatments with fewer side effects, offering new hope for patients. By focusing on specific immune system components, researchers aim to reduce inflammation and other symptoms associated with autoimmune conditions. This development suggests a growing interest in managing these diseases more effectively, as seen in the work of Ducos et al. (2025).
Clinical Trials
This is a list of upcoming or ongoing clinical trials that are actively recruiting and have been listed or updated in the last two weeks: